ARWR GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Arrowhead Pharmaceuticals Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.
Did you know?
Capital expenditures decreased by 84% from FY24 to FY25.
Current Price
$74.81
+1.81%Profile
Valuation (TTM)
Market Cap$10.16B
P/E50.23
EV—
P/B21.80
Shares Out135.81M
P/Sales9.31
Revenue$1.09B
EV/EBITDA29.30
Arrowhead Pharmaceuticals Inc (ARWR) Quality Analysis
ARWR Profitability
Profitability trend analysis coming soon
ARWR Growth
Growth trend analysis coming soon
ARWR Financial Health
Financial health indicators coming soon
ARWR Quality & Fundamental Analysis
Arrowhead Pharmaceuticals Inc (ARWR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. This quality analysis page evaluates Arrowhead Pharmaceuticals Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Arrowhead Pharmaceuticals Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 18.54% and a return on equity (ROE) of 43.40%. Return on assets (ROA) stands at 14.60%.
The debt-to-equity ratio is 1.57, with a current ratio of 4.86. Operating margin is 11.86%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Arrowhead Pharmaceuticals Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.